Morgan Stanley’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $815 | Sell |
503
-34,938
| -99% | -$56.6K | ﹤0.01% | 7353 |
|
|
2025
Q1 | $25.4K | Sell |
35,441
-124,469
| -78% | -$89.3K | ﹤0.01% | 6476 |
|
|
2024
Q4 | $178K | Buy |
159,910
+135,462
| +554% | +$150K | ﹤0.01% | 5835 |
|
|
2024
Q3 | $17.1K | Sell |
24,448
-144,852
| -86% | -$101K | ﹤0.01% | 6548 |
|
|
2024
Q2 | $169K | Buy |
169,300
+42,608
| +34% | +$42.6K | ﹤0.01% | 5748 |
|
|
2024
Q1 | $300K | Sell |
126,692
-217,430
| -63% | -$515K | ﹤0.01% | 5560 |
|
|
2023
Q4 | $774K | Buy |
344,122
+267,098
| +347% | +$601K | ﹤0.01% | 5422 |
|
|
2023
Q3 | $163K | Buy |
77,024
+30,802
| +67% | +$65.3K | ﹤0.01% | 5673 |
|
|
2023
Q2 | $143K | Sell |
46,222
-23,253
| -33% | -$71.9K | ﹤0.01% | 5794 |
|
|
2023
Q1 | $374K | Buy |
69,475
+52,521
| +310% | +$283K | ﹤0.01% | 5420 |
|
|
2022
Q4 | $113K | Buy |
16,954
+9,282
| +121% | +$61.7K | ﹤0.01% | 5928 |
|
|
2022
Q3 | $30K | Sell |
7,672
-22,598
| -75% | -$88.4K | ﹤0.01% | 6627 |
|
|
2022
Q2 | $150K | Buy |
30,270
+20,143
| +199% | +$99.8K | ﹤0.01% | 6037 |
|
|
2022
Q1 | $60K | Buy |
10,127
+892
| +10% | +$5.29K | ﹤0.01% | 6623 |
|
|
2021
Q4 | $108K | Sell |
9,235
-42,379
| -82% | -$496K | ﹤0.01% | 6396 |
|
|
2021
Q3 | $809K | Sell |
51,614
-60,844
| -54% | -$954K | ﹤0.01% | 5188 |
|
|
2021
Q2 | $2.1M | Buy |
+112,458
| New | +$2.1M | ﹤0.01% | 4594 |
|